Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experience BEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, announced the launch of its new corporate branding and website today, marking the next milestone of the Company's transformation to a retina-focused company. Ocular Therapeutix Logo ...
Bassett Announces Second Quarter Conference Call BASSETT, Va., June 26, 2025 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) today announced it will host a conference call with management on Thursday, July 10, 2025, at 9:00 a.m. ET to discuss its second quarter 2025 financial results. The Company will issue its earnings release after the market closes on Wednesday, July 9, 2025. Chairman and CEO Rob Spilman will host the call, along with CFO Mike Daniel. The public is invited to listen to the conference call by webcast, accessible through the Company’s investor rel...
UMH PROPERTIES, INC. WILL HOST SECOND QUARTER 2025 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL FREEHOLD, NJ, June 23, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced that it will host its Second Quarter 2025 Financial Results Webcast and Conference Call. Senior management will discuss the results, current market conditions and future outlook on Thursday, August 7, 2025, at 10:00 a.m. Eastern Time. UMH’s Second Quarter 2025 results will be released on Wednesday, August 6...
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 BEDFORD, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, 2025, in Las Vegas, NV. Clinical Trials at the Summit (CTS) 2025 Presentation Details: Company Presentation: Ocular TherapeutixSession: Diamond Sponsor TalksPresentation Date/Time: Friday, June 20, 2025, 7:55 – 8:05 PM PTPresen...
BRT Apartments Corp. Announces Quarterly Dividend GREAT NECK, N.Y., June 04, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT) announced today that its Board of Directors declared a quarterly dividend of $0.25 per share. The dividend is payable on July 9, 2025, to stockholders of record at the close of business on June 25, 2025. BRT is a real estate investment trust that owns, operates and, to a lesser extent, holds interests in joint ventures that own multi-family properties. As of March 31, 2025, BRT owns or has interests in 29 multi-family properties with 7,947 units in 11 sta...
Moody's Ratings (Moody's) has assigned a Ba1 long-term senior unsecured rating to Rocket Companies, Inc.'s (Rocket) new $4.0 billion backed senior unsecured notes and affirmed Rocket Mortgage, LLC's Ba1 long-term senior unsecured rating. We have also assigned a Ba1 corporate family rating (CFR) to R...
A director at CBRE Global Real Estate Income Fund sold 16,000 shares at 5.110USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
A director at BRT Apartments Corp bought 19,360 shares at 15.559USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial continues on track for top-line readout in 1Q 2026 These two complementary trials are intended to form the basis of an NDA submission of AXPAXLI in wet AMD BEDFORD, Mass., May 28, 2025 (G...
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2025 INVESTOR CONFERENCE FREEHOLD, NJ, May 27, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), today announced that the Company will participate in Nareit’s REITweek: 2025 Investor Conference, to be held in New York City, at the New York Hilton Midtown. UMH’s senior management team is scheduled to present on Tuesday, June 3, 2025, at 10:15 a.m. Eastern Time. The presentation will be available live via webcast and accessible on the Company’s website, , in the Upcoming Events section. The webcast replay will ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.